糖尿病設備市場規模、佔有率和成長分析（按類型、分銷管道、最終用途和地區）- 產業預測 2025-2032

預計 2023 年全球糖尿病設備市場規模將達到 333 億美元，並從 2024 年的 362.3 億美元成長到 2032 年的 711.4 億美元，預測期內（2025-2032 年）的複合年成長率為 8.8%。

全球疾病負擔不斷加劇，主要是由於久坐的生活方式和都市化的加速。根據國際糖尿病聯盟通報，全球約有5.3億20-79歲族群被診斷出患有糖尿病，與多種併發症有關，包括中風、心血管疾病和神經損傷。隨著人們對糖尿病管理認知的提高，這種令人擔憂的趨勢正在刺激對糖尿病管理設備的需求。為了滿足日益成長的消費者需求，胰島素幫浦、胰島素筆和其他先進的糖尿病治療技術的創新設計已經應運而生。因此，領先的製造商正專注於創新和開發尖端產品以佔領較大的市場佔有率，凸顯了增強糖尿病護理解決方案的迫切需求。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

糖尿病設備市場規模（按類型和複合年成長率）（2025-2032）

• 市場概況
• BGM 設備
  • 自我監測設備
  • 血糖值儀
  • 試紙
  • 《採血針》
  • 連續血糖監測裝置
  • 感應器
  • 發送器
  • 接收器
  • 胰島素注射裝置
  • 泵浦
  • 筆
  • 注射器
  • 噴射注射器

糖尿病設備市場規模（按分銷管道和複合年成長率） (2025-2032)

• 市場概況
• 醫院藥房
• 零售藥局
• 糖尿病診所/中心
• 網路藥局
• 其他

糖尿病設備市場規模（按最終用途和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 診斷中心
• 居家護理

糖尿病設備市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic（Ireland）
• Abbott Laboratories（United States）
• DexCom（United States）
• Novo Nordisk（Denmark）
• Becton, Dickinson and Company（United States）
• Roche（Switzerland）
• Insulet（United States）
• Tandem Diabetes Care（United States）
• Ypsomed（Switzerland）
• Sanofi（France）
• Eli Lilly and Company（United States）
• LifeScan（United States）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Bayer AG（Germany）
• Johnson & Johnson（United States）
• Terumo Corporation（Japan）
• AgaMatrix Holdings（United States）
• ARKRAY USA（United States）
• Nipro Corporation（Japan）

結論和建議

Global Diabetes Device Market size was valued at USD 33.3 billion in 2023 and is poised to grow from USD 36.23 billion in 2024 to USD 71.14 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global illness burden is escalating, primarily driven by increased sedentary lifestyles and urbanization. As reported by the International Diabetes Federation, approximately 530 million individuals aged 20 to 79 are diagnosed with diabetes, a condition linked to various complications such as strokes, cardiovascular issues, and nerve damage. This alarming trend is fueling the demand for diabetes management devices, as awareness of disease control intensifies. Innovatively designed insulin pumps, pens, and other advanced diabetic technologies are emerging to meet this growing consumer need. Consequently, leading manufacturers are focusing on technological innovations and developing cutting-edge products to capture significant market share, underscoring the urgent requirement for enhanced diabetes care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Device Market Segments Analysis

Global Diabetes Device Market is segmented by Type, Distribution Channel, End Use and region. Based on Type, the market is segmented into BGM Devices. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Device Market

The global diabetes device market is significantly propelled by the escalating prevalence of diabetes around the world. This surge can be attributed to various factors, including sedentary lifestyles, poor dietary choices, obesity, and an aging demographic. As more individuals receive a diabetes diagnosis, the demand for devices that facilitate effective management and monitoring of the condition intensifies. This growing need underscores the importance of innovative diabetes management technologies, as patients seek solutions to help maintain their health and improve their quality of life in the face of widespread diabetes-related challenges.

Restraints in the Global Diabetes Device Market

The Global Diabetes Device market faces significant restraints related to the accuracy and reliability of its products, which are vital for successful diabetes management. Some devices may present discrepancies in measurements or experience calibration problems and technical malfunctions, all of which can affect the consistency of the data reported. These inaccuracies pose the risk of leading to misguided treatment decisions, ultimately jeopardizing patient safety. To foster confidence among healthcare providers and individuals managing diabetes, it is imperative to prioritize the enhancement of these devices' accuracy and reliability, ensuring they can be trusted to deliver precise readings consistently.

Market Trends of the Global Diabetes Device Market

The Global Diabetes Device market is experiencing a significant trend toward the evolution of insulin delivery systems, characterized by a surge in smart technologies. Insulin pumps and pens are increasingly equipped with advanced features and connectivity options, exemplified by their integration with Continuous Glucose Monitoring (CGM) systems for real-time glucose reading and automated insulin adjustments. This innovation enhances convenience and precision in insulin delivery, enabling personalized treatment plans that markedly improve glycaemic control for patients. As a result, the market is likely to witness accelerated growth as healthcare providers and patients increasingly embrace these cutting-edge solutions for diabetes management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Diabetes Device Market Size by Type & CAGR (2025-2032)

• Market Overview
• BGM Devices
  • Self-Monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
  • Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receiver
  • Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes
  • Jet Injectors

Global Diabetes Device Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Global Diabetes Device Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Homecare

Global Diabetes Device Market Size & CAGR (2025-2032)

• North America (Type, Distribution Channel, End Use)
  • US
  • Canada
• Europe (Type, Distribution Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DexCom (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix Holdings (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY USA (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations